Search
logo
Search
The article is in preview mode

The following information is provided by the Commission to the European Parliament and to the Council

Homepage Articles The following information is provided by the Commission to the European Parliament and to the Council

The following information is provided by the Commission to the European Parliament and to the Council

One of these is inositol. How does it affect treatment? PCOS is one of the most common hormonal problems in women of childbearing age. What is its role in the body? Is it worth supplementing?

Table of Contents

1. In addition to this, it is necessary to ensure that the following information is kept in the file:

The most commonly used supplements with proven beneficial effects include vitamin D3, N-acetyl-L-cysteine (NAC), inositol, folic acid and microelements such as chromium, selenium and zinc. Kostecka 2018). It should be selected individually after analysing the results of the studies and taking into account factors such as age, body weight, associated symptoms and medicines. Some studies have also confirmed the effectiveness of omega-3s, vitamin E, bioflavoroids and herbal preparations (M. In addition to diet, supplementation may also be helpful.

2. Inositol plays a role in the body

This group is also known for its sweetening properties of xylitol, erythritol and sorbitol. It is essential for the proper functioning of the body because: is involved in the formation of cells, it is a precursor of phospholipids (e.g. lecithins), forms cell membranes, ?? it plays an important role in the metabolism of carbohydrates and fats. It is also important for the maturation of oocytes (active cells) participates in the production of certain hormones, i.e. it is also involved in protein synthesis (i.e., lecithin). In addition, it supplies the highest levels of nutrients to the body, as well as vitamins and minerals, affecting the body's natural metabolism, and protects the body by protecting the body and protecting it, e.g., in the form of vitamin B, vitamin B and vitamin C.

3. Effect of inositol on PCOS

Numerous studies have shown that the effectiveness of inositol at 12004000 mg per day has been evaluated for 6 months, with significant benefits for increasing fertility and the likelihood of pregnancy (Z. Gateva 2020). The study included 50 women with PCOS who experienced insulin resistance and/ or hyperinsulinemia. Treatment lasted 6 months and then the efficacy of insulin was evaluated The insulin index, monthly cycle length, and blood glucose levels of insulin were increased (Gateva 2020), as well as a significant reduction in insulin activity in menopausal women who received a dose of testosterone during the first two months of menopause, and a significant decrease in their body weight during the second half of the menstrual cycle, and the results of the study also showed a significant improvement in their metabolic rate.
Source

Artini P.G. et al., Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study, „Gynecological Endocrinology” 2013, 29(4), 375–379.
Croze M.L., Soulage Ch.O., Potential role and therapeutic interests of myo-inositol in metabolic diseases, „Biochimie” 2013, 95(10), 1811–1827.
Donà G. et al., Inositol administration reduces oxidative stress in erythrocytes of patients with polycystic ovary syndrome, „European Journal of Endocrinology” 2012, 166(4), 703–710.
Escobar-Morreale H.F., Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment, „Nature Reviews Endocrinology” 2018, 14(5), 270–284.
Fruzzetti F. et al., Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS), „Gynecological Endocrinology” 2017, 33(1), 39–42.
Genazzani A.D. et al., Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome, „Gynecological Endocrinology” 2008, 24(3), 139–144.
Kamenov Z., Gateva A., Inositols in PCOS, „Molecules” 2020, 25(23), epub.
Kostecka M., Zespół policystycznych jajników – rola diety i suplementacji we wspomaganiu leczenia, „Kosmos. Problemy nauk biologicznych” 2018, 4(321), 855–862.
Oner G., Muderris I.I., Clinical, endocrine and metabolic effects of metformin vs N-acetyl-cysteine in women with polycystic ovary syndrome, „European Journal of Obstetrics & Gynecology and Reproductive Biology” 2011, 159(1), 127–131.
Oszukowski P. et al., Stanowisko Zespołu Ekspertów Polskiego Towarzystwa Ginekologicznego dotyczące stosowania preparatów zawierających myo-inozytol przez pacjentki z zespołem policystycznych jajników (PCOS), „Ginekologia Polska” 2014, 85, 158–160.
Papaleo E. et al., Myo-inositol in patients with polycystic ovary syndrome: A novel method for ovulation induction, „Gynecological Endocrinology” 2007, 23(12), 700–703.
Unfer V. et al., Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials, „Endocrine Connections” 2017, 6(8), 647–658.
Zespół policystycznych jajników – zalecenia dietetyczne, ncez.pzh.gov.pl/wp-content/uploads/2021/08/zalecenia_dietetycy_zespol_policystycznych_jajnikow.pdf (26.06.2022).